COPD Clinical Trials near Chicago, IL
20 studies for COPD are recruiting at 30 sites within 50 miles of Chicago, Illinois, according to ClinicalTrials.gov data processed .
Distances are city-level approximations. See all COPD trials in the US or all trials near Chicago.
Recruiting now
COPD studies enrolling near Chicago
- A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
NCT06283966
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest sites: Research Site (Chicago, IL); Research Site (Winfield, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
NCT07190209
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest sites: University of Illinois-Chicago - College of Medicine- Site Number : 8400055 (Chicago, IL); Avicenna Clinical Research- Site Number : 8400126 (Chicago Ridge, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- STRIVE Post-Market Registry Study
NCT04302272
- Observational
- Ages 18 years and older
- Sex: All
Nearest sites: Northwestern University, Division of Pulmonary and Critical Care Medicine (Chicago, IL); University of Chicago (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
NCT06035120
- Interventional
- Ages 40 to 80 years
- Sex: All
Nearest sites: Northwestern University (Chicago, IL); University of Chicago Medical Center (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
NCT06122077
- Observational
- Ages 50 years and older
- Sex: All
Nearest sites: University of Chicago (Chicago, IL); Walgreens (Deerfield, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- SPIROMICS Study of Early COPD Progression (SOURCE)
NCT05033990
- Observational
- Ages 30 to 55 years
- Sex: All
- Accepts healthy volunteers
Nearest site: University of Illinois Chicago (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
NCT05204888
- Interventional
- Ages 30 years and older
- Sex: All
Nearest site: University of Chicago (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention
NCT06390345
- Interventional
- Ages 18 years and older
- Sex: All
Nearest site: Jesse Brown VA Medical Center (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
NCT06891755
- Interventional
- Ages 40 to 84 years
- Sex: All
Nearest site: University of Chicago (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
NCT06959095
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest site: GSK Investigational Site (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
NCT06961214
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest site: GSK Investigational Site (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
NCT07059091
- Phase 2
- Ages 40 years and older
- Sex: All
Nearest site: Northwestern University (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Multi Center Study Testing a New Implant for Adults With Severe Emphysema
NCT07119229
- Interventional
- Ages 22 years and older
- Sex: All
Nearest site: Northwestern University (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- COPD Resources, Education, and Activity Designed for You Study
NCT07125053
- Interventional
- Ages 40 years and older
- Sex: All
Nearest site: Rush University Medical Center (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
NCT07759245
- Phase 2
- Ages 40 to 75 years
- Sex: All
Nearest site: Axis Clinical Trials - Westchester (Westchester, IL)
- Distance to nearest recruiting site
- ~12 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
NCT06878261
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest site: Research Site (Evanston, IL)
- Distance to nearest recruiting site
- ~13 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
NCT06883305
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest sites: Research Site (Palos Hills, IL); Research Site (Munster, IN)
- Distance to nearest recruiting site
- ~14 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- COPD Exacerbation Follow Up
NCT07118306
- Observational
- Ages 40 years and older
- Sex: All
Nearest site: Advocate Lutheran General Hospital (Park Ridge, IL)
- Distance to nearest recruiting site
- ~15 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
NCT07363694
- Phase 2/3
- Ages 35 to 80 years
- Sex: All
Nearest sites: ASHA Clinical Research - Munster, LLC (Hammond, IN); Methodist Hospital Southlake (Merrillville, IN)
- Distance to nearest recruiting site
- ~20 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
NCT07190222
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest site: Asha Clinical Research - Munster- Site Number : 8400115 (Hammond, IN)
- Distance to nearest recruiting site
- ~20 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
FAQ
Common questions
What is a clinical trial?
Is there compensation for joining a COPD clinical trial?
How do I check if I'm eligible?
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.